You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Aurora A Kinase Inhibitor

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Lung Non-Squamous Non-Small Cell Carcinoma, Metastatic Lung Non-Squamous Non-Small Cell Carcinoma, Stage III Lung

Recruiting
  • Advanced Lung Non-Squamous Non-Small Cell Carcinoma
  • +8 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 29, 2022

Solid Tumors Trial in Buffalo, San Antonio (CYC116)

Terminated
  • Solid Tumors
  • Buffalo, New York
  • +1 more
Dec 7, 2021

Lung Cancer, Non Small Cell Lung Cancer Trial in Aurora (Amivantamab 1050mg, Amivantamab 1400mg, Amivantamab (to be determined))

Not yet recruiting
  • Lung Cancer
  • Non Small Cell Lung Cancer
  • Amivantamab 1050mg
  • +2 more
  • Aurora, Colorado
  • +2 more
Apr 25, 2023

Liver Cancer, Hepatocellular Carcinoma, Resistant Cancer Trial in Shanghai (Lenvatinib Oral Product Plus VIC1911)

Not yet recruiting
  • Liver Cancer
  • +2 more
  • Lenvatinib Oral Product Plus VIC1911
  • Shanghai, China
    Deparment of Liver Surgery, Ren Ji Hospital, School of Medicine,
Jan 30, 2023

NSCLC Trial in United States (VIC-1911, sotorasib)

Recruiting
  • Non-small Cell Lung Cancer
  • Sacramento, California
  • +4 more
Jan 5, 2023

Non Small Cell Lung Cancer, NSCLC, NSCLC Trial in Australia, Korea, Republic of, United States (TPX-0131)

Active, not recruiting
  • Non Small Cell Lung Cancer
  • +5 more
  • Orange, California
  • +13 more
Nov 7, 2022

Head and Neck Squamous Cell Carcinoma, Malignant Solid Tumor Trial in Houston (Alisertib, Pembrolizumab)

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Malignant Solid Neoplasm
  • Houston, Texas
    M D Anderson Cancer Center
Dec 31, 2022

Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Non-Small Cell Cancer AJCC v7

Active, not recruiting
  • Metastatic Lung Non-Small Cell Carcinoma
  • +2 more
  • Duarte, California
  • +14 more
Jan 27, 2023

Amyotrophic Lateral Sclerosis Trial in Australia, United States (Fasudil (WP-0512))

Recruiting
  • Amyotrophic Lateral Sclerosis
  • Fasudil (WP-0512)
  • Phoenix, Arizona
  • +11 more
Oct 28, 2022

NSCLC ALK-positive, NSCLC c-Met Dependent, NSCLC ROS Marker Positive Trial in Worldwide (PF-02341066, Rifampin, Itraconazole)

Completed
Has Results
  • Non-Small Cell Lung Cancer ALK-positive
  • +4 more
  • Orange, California
  • +28 more
Feb 15, 2022

Recurrent Lung Non-Small Cell Carcinoma, Stage IIIB Lung Cancer AJCC v8, Stage IV Lung Cancer AJCC v8 Trial in Houston

Active, not recruiting
  • Recurrent Lung Non-Small Cell Carcinoma
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 31, 2022

Pancreatic Ductal Adenocarcinoma Trial (combination therapy with no MEKi, combination therapy with MEKi-HCQ, combination therapy

Not yet recruiting
  • Pancreatic Ductal Adenocarcinoma
  • combination therapy with no MEKi
  • +3 more
  • (no location specified)
Nov 29, 2022

Refractory Cancer, Refractory Tumor, Cancer Pediatric Trial in United States (9-ING-41, Irinotecan, Temozolomide)

Recruiting
  • Refractory Cancer
  • +10 more
  • Aurora, Colorado
  • +7 more
Dec 31, 2022

Acute Megakaryoblastic Leukemia, Myelofibrosis, Primary Myelofibrosis Trial in Miami, Chicago, Rochester (Alisertib, Laboratory

Active, not recruiting
Has Results
  • Acute Megakaryoblastic Leukemia
  • +2 more
  • Miami, Florida
  • +2 more
May 4, 2021

Tumor Feeding Vessels Deprivation Combined With Tyrosine Kinase

Recruiting
  • Liver Transplant
  • PVHA or TACE
  • Shanghai, Shanghai, China
    The value of tumor feeding vessels deprivation combined with tyr
Nov 26, 2022

Non-Hodgkins Lymphoma, Solid Tumor Trial in Vancouver, Ottawa (Aurora kinase inhibitor AT9283)

Completed
  • Non-Hodgkins Lymphoma
  • Unspecified Adult Solid Tumor, Protocol Specific
  • Aurora kinase inhibitor AT9283
  • Vancouver, British Columbia, Canada
  • +1 more
Apr 6, 2020

Cushing Disease Trial (Fimepinostat)

Not yet recruiting
  • Cushing Disease
  • (no location specified)
Jul 31, 2023

Advanced Solid Tumor, Metastatic Solid Tumor Trial (PEP07)

Not yet recruiting
  • Advanced Solid Tumor
  • Metastatic Solid Tumor
  • (no location specified)
Aug 1, 2023

Neuroblastoma Trial in Worldwide (LY3295668 Erbumine, Topotecan, Cyclophosphamide)

Active, not recruiting
  • Neuroblastoma
  • LY3295668 Erbumine
  • +2 more
  • San Francisco, California
  • +21 more
Aug 17, 2022

Adenocarcinoma of the Lung, Extensive Stage Small Cell Lung Cancer, Limited Stage Small Cell Lung Cancer Trial in Aurora

Completed
Has Results
  • Adenocarcinoma of the Lung
  • +7 more
  • Aurora, Colorado
    University of Colorado Cancer Center
Jan 19, 2022

Columnar Cell Variant Thyroid Gland Papillary Carcinoma, Follicular Variant Thyroid Gland Papillary Carcinoma, Metastatic

Active, not recruiting
  • Columnar Cell Variant Thyroid Gland Papillary Carcinoma
  • +25 more
  • Laboratory Biomarker Analysis
  • +3 more
  • Torrance, California
  • +6 more
Jan 12, 2023

Liver Tumors Trial in Beijing (Tislelizumab plus tyrosine kinase inhibitor)

Recruiting
  • Liver Neoplasms
  • Tislelizumab plus tyrosine kinase inhibitor
  • Beijing, Beijing, China
    302 Hospital
Sep 22, 2023

Cyclin-dependent Kinase Inhibitor 2A on Labor-related Signals

Not yet recruiting
  • Preterm Labor
    • (no location specified)
    May 9, 2023

    Advanced Lung Non-Squamous Non-Small Cell Carcinoma, Metastatic Lung Non-Squamous Non-Small Cell Carcinoma, Stage III Lung

    Active, not recruiting
    • Advanced Lung Non-Squamous Non-Small Cell Carcinoma
    • +5 more
    • Sacramento, California
    • +17 more
    Aug 2, 2022

    Acute Myeloid Leukemia, Lymphoma, Mantle-Cell Trial (PEP07)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • Lymphoma, Mantle-Cell
    • (no location specified)
    Dec 22, 2022